[no abstract]

Monoclonal antibodies are increasingly dominating the market for human therapeutic and diagnostic agents. For this reason, continuous methods—such as perfusion processes—are being explored and optimized in an ongoing effort ...

Monoclonal antibodies (mAbs) are becoming increasingly important as biopharmaceutical product. The high specific affinity of mAbs is successfully used for the therapy of numerous severe diseases, such as autoimmune diseases, ...